The basics: Diagnostic terms, skin anatomy, and stains

Published on 08/03/2015 by admin

Filed under Dermatology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 5 (1 votes)

This article have been viewed 10005 times

Chapter 1

The basics

Diagnostic terms, skin anatomy, and stains

Glossary of terms

Lichenoid dermatitis

Normal skin anatomy

Hair anatomy

Bulb

Anagen hairs have a stem and a bulb which produces the hair shaft, whereas telogen hairs lack an inferior segment. Telogen hairs are easily recognized in vertical sections, as the club hair and surrounding trichilemmal keratin give the impression of a flame thrower.

Nail anatomy

Types of inflammatory cells

Histochemical stains

The affinities of various dyes have been exploited as histochemical “special” stains to aid in identification of cell type, mucopolysaccharides, muscle, lipid, iron, melanin, calcium, elastin, collagen, amyloid, and infectious organisms. Hematoxylin and eosin (H&E) is the routine staining choice for microscopic interpretation resulting in blue nuclei and pink cytoplasm.

Carbohydrate stains

PAS (Periodic acid-Schiff)

Other “special” stains

Immunohistochemical stains

Histochemical stains are now being supplemented by immunohistochemical techniques in fixed, paraffin-embedded tissue. Antibodies directed towards the antigen of interest are conjugated to peroxidases. Enzyme histochemical reactions for the peroxidase, such as diaminobenzidine method (DAB), are used to visualize the presence of enzyme–antibody–antigen complex fixed to tissue as a stable brown product. 3-amino-9-ethylcarbazole (AEC) can alternatively be used giving a red reaction, but does not archive as well.

Immunopathologic antibodies are used in dermatopathology to differentiate carcinoma, melanoma, sarcoma, neural neoplasms, and lymphomas. A panel of antibodies is generally recommended rather than a single stain because aberrant staining is common in neoplasms. Independent and internal controls should be assessed to assure proper reactivity.

Epithelial markers

Mesenchymal markers

Neuroectodermal markers

Hematopoietic markers

BCL2

Further reading

Alcaraz, I, Cerroni, L, Rütten, A, et al. Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review. Am J Dermatopathol. 2012; 34(4):347–393.

Anstey, A, Cerio, R, Ramnarain, N, et al. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases. Am J Dermatopathol. 1994; 16(1):14–22.

Bahrami, S, Malone, JC, Lear, S, et al. CD10 expression in cutaneous adnexal neoplasms and a potential role for differentiating cutaneous metastatic renal cell carcinoma. Arch Pathol Lab Med. 2006; 130(9):1315–1319.

Benner, MF, Jansen, PM, Meijer, CJ, et al. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders. Br J Dermatol. 2009; 161(1):121–127.

Buonaccorsi, JN, Plaza, JA. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases. Am J Dermatopathol. 2012; 34(4):404–411.

Córdoba, A, Guerrero, D, Larrinaga, B, et al. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation. Int J Dermatol. 2009; 48(7):713–717.

Cota, C, Vale, E, Viana, I, et al. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients. Am J Surg Pathol. 2010; 34(1):75–87.

Elston, DM, Gibson, LE, Kutzner, H. Infectious diseases. In: Lin F, Prichard J, eds. Handbook of Practical Immunohistochemistry. New York: Springer, 2011.

Eyzaguirre, E, Haque, AK. Application of immunohistochemistry to infections. Arch Pathol Lab Med. 2008; 132(3):424–431.

Fox, MD, Billings, SD, Gleason, BC, et al. Expression of MiTF may be helpful in differentiating cellular neurothekeoma from plexiform fibrohistiocytic tumor (histiocytoid predominant) in a partial biopsy specimen. Am J Dermatopathol. 2012; 34(2):157–160.

Fullen, DR, Lowe, L, Su, LD. Antibody to S100a6 protein is a sensitive immunohistochemical marker for neurothekeoma. J Cutan Pathol. 2003; 30(2):118–122.

Fullen, DR, Reed, JA, Finnerty, B, et al. S100A6 expression in fibrohistiocytic lesions. J Cutan Pathol. 2001; 28(5):229–234.

Helm, KF. Immunohistochemistry of skin tumors. In: Dabbs DJ, ed. Diagnostic Immunohistochemistry. Philadelphia: Churchill Livingstone; 2002:313–327.

Hoefnagel, JJ, Vermeer, MH, Jansen, PM, et al. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance. Br J Dermatol. 2003; 149(6):1183–1191.

Hudson, AR, Smoller, BR. Immunohistochemistry in diagnostic dermatopathology. Dermatol Clin. 1999; 17(3):667–680.

Kucher, C, Xu, X, Pasha, T, et al. Histopathologic comparison of nephrogenic fibrosing dermopathy and scleromyxedema. J Cutan Pathol. 2005; 32(7):484–490.

Lau, SK, Chu, PG, Weiss, LM. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol. 2008; 32(4):615–619.

Lazova, R, Tantcheva-Poor, I, Sigal, AC. P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma. J Am Acad Dermatol. 2010; 63(5):852–858.

Lora, V, Kanitakis, J. CDX2 expression in cutaneous metastatic carcinomas and extramammary Paget’s Disease. Anticancer Res. 2009; 29(12):5033–5037.

Macarenco, RS, Ellinger, F, Oliveira, AM. Perineurioma: a distinctive and underrecognized peripheral nerve sheath neoplasm. Arch Pathol Lab Med. 2007; 131(4):625–636.

Mohamed, A, Gonzalez, RS, Lawson, D, et al. SOX10 expression in malignant melanoma, carcinoma, and normal tissues. Appl Immunohistochem Mol Morphol. 2012.

Murphy, M, Fullen, D, Carlson, JA. Low CD7 expression in benign and malignant cutaneous lymphocytic infiltrates: experience with an antibody reactive with paraffin-embedded tissue. Am J Dermatopathol. 2002; 24(1):6–16.

North, PE, Waner, M, Mizeracki, A, et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangioma. Hum Pathol. 2000; 31(1):11–22.

Ostler, DA, Prieto, VG, Reed, JA, et al. Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 cases. Mod Pathol. 2010; 23(4):567–573.

Perna, AG, Smith, MJ, Krishnan, B, et al. CD10 is expressed in cutaneous clear cell lesions of different histogenesis. J Cutan Pathol. 2005; 32(5):348–351.

Pilloni, L, Bianco, P, Difelice, E, et al. The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions. Eur J Histochem. 2011; 55(2):e20.

Plaza, JA, Ortega, PF, Stockman, DL, et al. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. J Cutan Pathol. 2010; 37(4):403–410.

Poniecka, AW, Alexis, JB. An immunohistochemical study of basal cell carcinoma and trichoepithelioma. Am J Dermatopathol. 1999; 21(4):332–336.

Pouryazdanparast, P, Yu, L, Cutlan, JE, et al. Diagnostic value of CD163 in cutaneous spindle cell lesions. J Cutan Pathol. 2009; 36(8):859–864.

Ribé, A, McNutt, NS. S100A6 protein expression is different in Spitz nevi and melanomas. Mod Pathol. 2003; 16(5):505–511.

Rose, AE, Christos, PJ, Lackaye, D, et al. Clinical relevance of detection of lymphovascular invasion in primary melanoma using endothelial markers D2-40 and CD34. Am J Surg Pathol. 2011; 35(10):1441–1449.

Roullet, M, Gheith, SM, Mauger, J, et al. Percentage of γδ T cells in panniculitis by paraffin immunohistochemical analysis. Am J Clin Pathol. 2009; 131(6):820–826.

Sachdev, R, Robbins, J, Kohler, S, et al. CD163 expression is present in cutaneous histiocytomas but not in atypical fibroxanthomas. Am J Clin Pathol. 2010; 133(6):915–921.

Saglam, A, Uner, AH. Immunohistochemical expression of Mum-1, Oct-2 and Bcl-6 in systemic anaplastic large cell lymphomas. Tumori. 2011; 97(5):634–638.

Schach, CP, Smoller, BR, Hudson, AR, et al. Immunohistochemical stains in dermatopathology. J Am Acad Dermatol. 2000; 43:1094–1100.

Schimming, TT, Grabellus, F, Roner, M, et al. pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas. Am J Dermatopathol. 2012; 34(3):266–269.

Shin, J, Vincent, JG, Cuda, JD, et al. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses. J Am Acad Dermatol. 2012; 67(4):717–726.

Skobieranda, K, Helm, KF. Decreased expression of the human progenitor cell antigen (CD34) in morphea. Am J Dermatopathol. 1995; 17(5):471–475.

Smith, KJ, Tuur, S, Corvette, D, et al. Cytokeratin 7 staining in mammary and extramammary Paget’s disease. Mod Pathol. 1997; 10(11):1069–1074.

Su, LD, Schnitzer, B, Ross, CW, et al. The t(2; 5)-associated p80 NPM/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders. J Cutan Pathol. 1997; 24(10):597–603.

Tellechea, O, Reis, JP, Domingues, JC, et al. Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin. Am J Dermatopathol. 1993; 15(5):452–455.

Vitte, F, Fabiani, B, Bénet, C, et al. Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases. Am J Surg Pathol. 2012; 36(9):1302–1316.

White, WL. Immunomicroscopy in diagnostic dermatopathology: an update on cutaneous neoplasms. Adv Dermatol. 1999; 14:359–397.

Wood, WS, Tron, VA. Analysis of HMB-45 immunoreactivity in common and cellular blue nevi. J Cutan Pathol. 1991; 18(4):261–263.

Share this: